Skip navigation
Agenda

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

June 5-7, 2018
  • Toronto, Canada

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, JUNE 5, 2018

12:00

Conference Registration and Refreshments

1:00 – 4:30

CHOOSE BETWEEN 2 PRE-CONFERENCE WORKSHOPS (I-II)

WORKSHOP I Examining the Evolution of Medical Affairs, Medical Affairs Governance and Compliance Implications

I. Medical Affairs Evolution

WORKSHOP CHAIR:

Fran Paradiso-Hardy
Senior Director, Medical Affairs
Astellas Pharma Canada

PRESENTERS:

Babak Abbaszadeh, MD, MBA
Country Medical Director
BMS Canada

Monique Furlan
Medical Science Liaison Head,
Diabetes & Cardiovascular care - Medical Affairs
Sanofi

II. Understanding the Impact of the MA Evolution from a Governance and Compliance Perspective

WORKSHOP CHAIR:

Shurjeel Choudhri, MD FRCPC
Senior Vice President and Head,
Medical and Scientific Affairs
Bayer Inc.

PRESENTERS:

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

Dr. Alex Romanovschi, MD
Director, Medical Affairs – Respiratory
GSK Canada

PANELIST:

Sue Sibley
Director, Medical Governance
Bayer Canada

 
WORKSHOP II Applying Health Care Compliance Principals within the
Medical Device Sector

I. Understand the Key Components of the
MEDEC Code of Conduct

PRESENTER:

Phil Spencer, QC
Principal
Life Sciences Counsel

II. Review of Health Care Compliance Related Considerations and Implications — Medical Device Perspective

PRESENTERS:

Andrea Freund
Vice President, Law
Johnson & Johnson Medical Products

Stephan Ekmekjian
Health Care Compliance Officer,
Medical Devices Canada
Johnson & Johnson

III. Deep Dive — Managing
Third-Party Intermediaries

PRESENTER:

Richard Khambatta
Compliance Officer
Valeant Canada

DAY TWO WEDNESDAY, JUNE 6, 2018

7:15

Registration and Continental Breakfast

8:15

Co-Chair’s Welcome and Opening Remarks

Crawford Wright
Chief Compliance and Privacy Officer
AstraZeneca Canada

8:30

KEYNOTE PRESENTATION
The Future of Ethics and Compliance

Chris MacDonald
Associate Professor, Ted Rogers School of Management
Ryerson University

9:15

Open Dialogue Session — Compliance and Ethics Code Interpretations

MODERATOR:

Crawford Wright
Chief Compliance and Privacy Officer
AstraZeneca Canada

PANELISTS:

Brian Lewis
President & CEO
MEDEC

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

Ray Chepesiuk
Commissioner
PAAB

Nicole Bellam
Vice President
Ad Standards Clearance Services

10:00

Networking and Refreshment Break

10:30

Understand Current Interpretations and Reporting Requirements of the New Ontario Health Sector Payment Transparency Act, 2017

Timothy Squire
Partner
Fasken, LLP

Amie Phillips Pablo
Associate Director, Compliance Government Reporting
Novo Nordisk Inc.

11:15

PANEL DISCUSSION
Critical Factors in Implementing HCP Disclosures Transparency Reporting

MODERATOR:

John Oroho
Executive Vice President and Chief Strategy Officer
Porzio Life Sciences, LLC

PANELISTS:

Jill Daley
General Counsel
Eli Lilly

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

12:00

Networking Luncheon

1:00

Lessons from the U.S. Compliance Landscape — From U.S. Federal Sentencing Guidelines, to CIAs, to OIG & DOJ Guidance and Enforcement

Michael Mayes
Head of Compliance,
Astellas International Business and Global Marketing Strategies
Astellas Pharma

1:45

Implementing a Data Collection and Data Management Process to Support Transparency Reporting and Beyond

Darren Jones
Partner
Polaris, a QuintilesIMS company

2:30

CHOOSE FROM 3 CONCURRENT, FOCUSED WORKSHOPS (A-C)

WORKSHOP A
Mitigating Conflict of Interest and Maintaining Compliance within Clinical Trials, Grants/Donations and Academic Partnerships

Rosy Sasso
Ethics, Compliance and Privacy Consultant
Rosy Sasso, Inc.

Joanne Skedelsky
Head, Pharma Integrity & Compliance and Country Compliance Head
Novartis Canada

WORKSHOP B
The Distinction Between Advertising and Other Activities & Perspectives from the Section of Transparency and Advertising Regulatory Surveillance

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

WORKSHOP C
Developing a Risk Management Framework

Richard Khambatta
Compliance Officer
Valeant Canada

Suzanne Senior-Mitchell
Compliance Counsel, Legal, Business Ethics & Quality
Novo Nordisk Canada Inc.

3:45

Networking and Refreshment Break

4:15

CHOOSE FROM 3 CONCURRENT, FOCUSED WORKSHOPS (D-F)

WORKSHOP D
Medical Device Compliance

Brian Lewis
President & CEO
MEDEC

Stephan Ekmekjian
Health Care Compliance Officer, Medical Devices Canada
Johnson & Johnson

WORKSHOP E
The Art of Effective Cross-Functional Partnering

Ratika Gandhi
Head of Legal and Compliance
Alcon Canada, Inc.

Lesia Babiak
Executive Director, Worldwide Government Affairs & Policy (Canada)
Johnson & Johnson

WORKSHOP F
Managing Third-Party Relationships

Michael Mayes
Head of Compliance, Astellas International Business and Global Marketing Strategies
Astellas Pharma

5:30

Patient Support Programs —
Understanding the Risks, Preparing for Compliance Audits

Erin Murphy
Head of Operational Excellence
EMD Serono Canada, Inc.

Anne Mayrand
Director, Legal and Compliance
Merck Canada

6:15

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE THURSDAY, JUNE 7, 2018

7:30

Continental Breakfast and Networking

8:00

Co-Chair’s Opening Remarks and Summary of Day Two

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

8:15

PANEL DISCUSSION
Aligning the Organization’s Perspective on the Role of Compliance

MODERATOR:

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

PANELISTS:

Lisa Matar
President and General Manager
Eli Lilly Canada Inc.

Lesia Babiak
Executive Director, Worldwide Government Affairs & Policy (Canada)
Johnson & Johnson

Michael Mayes
Head of Compliance, Astellas International Business and Global Marketing Strategies
Astellas Pharma

9:00

How Does Canada Compare When It Comes to Ethics and Compliance?

Chrisoula Nikidis
Canadian Head of Compliance and Ethics Solutions
Polaris, a QuintilesIMS company

9:45

Managing Conflict of Interest and Ethics — Perception Versus Reality

Rosy Sasso
Ethics, Compliance and Privacy Consultant
Rosy Sasso, Inc.

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

Chris MacDonald
Associate Professor, Ted Rogers School of Management
Ryerson University

10:30

Networking and Refreshment Break

11:00

Compliance in the Digital Era

Jordana Sanft
Partner, Lawyer, Trade-mark Agent, Patent Agent
Norton Rose Fulbright

Sara Zborovski
Partner, Lawyer
Norton Rose Fulbright

11:45

Internal Audit of the Future

Prashant Masand
Senior Manager, Risk Advisory
Deloitte

12:30

Networking Luncheon

1:45

Charting the Course to Proactively Manage Emerging Issues in Data Privacy

Frederique Desruisseaux
Head, Data Privacy Canada and Country Privacy Officer
Novartis Pharmaceuticals Canada Inc.

2:30

Managing Consent as Data Privacy is Impacted by an Evolving
Automated Landscape

Ywe Looper
Head, Legal and Compliance
Boehringer Ingelheim Canada

3:15

Key Strategies for Maintaining Compliant Interactions with the Drug Supply Chain

Mathieu Gagné, LLM, LLD
Partner
Fasken, LLP

4:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, JUNE 5, 2018

12:00

Conference Registration and Refreshments

1:00 – 4:30

CHOOSE BETWEEN 2 PRE-CONFERENCE WORKSHOPS (I-II)

WORKSHOP I Examining the Evolution of Medical Affairs, Medical Affairs Governance and Compliance Implications

I. Medical Affairs Evolution

WORKSHOP CHAIR:

Fran Paradiso-Hardy
Senior Director, Medical Affairs
Astellas Pharma Canada

PRESENTERS:

Babak Abbaszadeh, MD, MBA
Country Medical Director
BMS Canada

Monique Furlan
Medical Science Liaison Head,
Diabetes & Cardiovascular care - Medical Affairs
Sanofi

II. Understanding the Impact of the MA Evolution from a Governance and Compliance Perspective

WORKSHOP CHAIR:

Shurjeel Choudhri, MD FRCPC
Senior Vice President and Head,
Medical and Scientific Affairs
Bayer Inc.

PRESENTERS:

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

Dr. Alex Romanovschi, MD
Director, Medical Affairs – Respiratory
GSK Canada

PANELIST:

Sue Sibley
Director, Medical Governance
Bayer Canada

 
WORKSHOP II Applying Health Care Compliance Principals within the
Medical Device Sector

I. Understand the Key Components of the
MEDEC Code of Conduct

PRESENTER:

Phil Spencer, QC
Principal
Life Sciences Counsel

II. Review of Health Care Compliance Related Considerations and Implications — Medical Device Perspective

PRESENTERS:

Andrea Freund
Vice President, Law
Johnson & Johnson Medical Products

Stephan Ekmekjian
Health Care Compliance Officer,
Medical Devices Canada
Johnson & Johnson

III. Deep Dive — Managing
Third-Party Intermediaries

PRESENTER:

Richard Khambatta
Compliance Officer
Valeant Canada

DAY TWO WEDNESDAY, JUNE 6, 2018

7:15

Registration and Continental Breakfast

8:15

Co-Chair’s Welcome and Opening Remarks

Crawford Wright
Chief Compliance and Privacy Officer
AstraZeneca Canada

8:30

KEYNOTE PRESENTATION
The Future of Ethics and Compliance

Chris MacDonald
Associate Professor, Ted Rogers School of Management
Ryerson University

9:15

Open Dialogue Session — Compliance and Ethics Code Interpretations

MODERATOR:

Crawford Wright
Chief Compliance and Privacy Officer
AstraZeneca Canada

PANELISTS:

Brian Lewis
President & CEO
MEDEC

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

Ray Chepesiuk
Commissioner
PAAB

Nicole Bellam
Vice President
Ad Standards Clearance Services

10:00

Networking and Refreshment Break

10:30

Understand Current Interpretations and Reporting Requirements of the New Ontario Health Sector Payment Transparency Act, 2017

Timothy Squire
Partner
Fasken, LLP

Amie Phillips Pablo
Associate Director, Compliance Government Reporting
Novo Nordisk Inc.

11:15

PANEL DISCUSSION
Critical Factors in Implementing HCP Disclosures Transparency Reporting

MODERATOR:

John Oroho
Executive Vice President and Chief Strategy Officer
Porzio Life Sciences, LLC

PANELISTS:

Jill Daley
General Counsel
Eli Lilly

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

12:00

Networking Luncheon

1:00

Lessons from the U.S. Compliance Landscape — From U.S. Federal Sentencing Guidelines, to CIAs, to OIG & DOJ Guidance and Enforcement

Michael Mayes
Head of Compliance,
Astellas International Business and Global Marketing Strategies
Astellas Pharma

1:45

Implementing a Data Collection and Data Management Process to Support Transparency Reporting and Beyond

Darren Jones
Partner
Polaris, a QuintilesIMS company

2:30

CHOOSE FROM 3 CONCURRENT, FOCUSED WORKSHOPS (A-C)

WORKSHOP A
Mitigating Conflict of Interest and Maintaining Compliance within Clinical Trials, Grants/Donations and Academic Partnerships

Rosy Sasso
Ethics, Compliance and Privacy Consultant
Rosy Sasso, Inc.

Joanne Skedelsky
Head, Pharma Integrity & Compliance and Country Compliance Head
Novartis Canada

WORKSHOP B
The Distinction Between Advertising and Other Activities & Perspectives from the Section of Transparency and Advertising Regulatory Surveillance

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

WORKSHOP C
Developing a Risk Management Framework

Richard Khambatta
Compliance Officer
Valeant Canada

Suzanne Senior-Mitchell
Compliance Counsel, Legal, Business Ethics & Quality
Novo Nordisk Canada Inc.

3:45

Networking and Refreshment Break

4:15

CHOOSE FROM 3 CONCURRENT, FOCUSED WORKSHOPS (D-F)

WORKSHOP D
Medical Device Compliance

Brian Lewis
President & CEO
MEDEC

Stephan Ekmekjian
Health Care Compliance Officer, Medical Devices Canada
Johnson & Johnson

WORKSHOP E
The Art of Effective Cross-Functional Partnering

Ratika Gandhi
Head of Legal and Compliance
Alcon Canada, Inc.

Lesia Babiak
Executive Director, Worldwide Government Affairs & Policy (Canada)
Johnson & Johnson

WORKSHOP F
Managing Third-Party Relationships

Michael Mayes
Head of Compliance, Astellas International Business and Global Marketing Strategies
Astellas Pharma

5:30

Patient Support Programs —
Understanding the Risks, Preparing for Compliance Audits

Erin Murphy
Head of Operational Excellence
EMD Serono Canada, Inc.

Anne Mayrand
Director, Legal and Compliance
Merck Canada

6:15

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE THURSDAY, JUNE 7, 2018

7:30

Continental Breakfast and Networking

8:00

Co-Chair’s Opening Remarks and Summary of Day Two

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

8:15

PANEL DISCUSSION
Aligning the Organization’s Perspective on the Role of Compliance

MODERATOR:

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

PANELISTS:

Lisa Matar
President and General Manager
Eli Lilly Canada Inc.

Lesia Babiak
Executive Director, Worldwide Government Affairs & Policy (Canada)
Johnson & Johnson

Michael Mayes
Head of Compliance, Astellas International Business and Global Marketing Strategies
Astellas Pharma

9:00

How Does Canada Compare When It Comes to Ethics and Compliance?

Chrisoula Nikidis
Canadian Head of Compliance and Ethics Solutions
Polaris, a QuintilesIMS company

9:45

Managing Conflict of Interest and Ethics — Perception Versus Reality

Rosy Sasso
Ethics, Compliance and Privacy Consultant
Rosy Sasso, Inc.

Annie Bourgault
Ethics & Compliance Officer, Canada Pharmaceuticals
GSK

Chris MacDonald
Associate Professor, Ted Rogers School of Management
Ryerson University

10:30

Networking and Refreshment Break

11:00

Compliance in the Digital Era

Jordana Sanft
Partner, Lawyer, Trade-mark Agent, Patent Agent
Norton Rose Fulbright

Sara Zborovski
Partner, Lawyer
Norton Rose Fulbright

11:45

Internal Audit of the Future

Prashant Masand
Senior Manager, Risk Advisory
Deloitte

12:30

Networking Luncheon

1:45

Charting the Course to Proactively Manage Emerging Issues in Data Privacy

Frederique Desruisseaux
Head, Data Privacy Canada and Country Privacy Officer
Novartis Pharmaceuticals Canada Inc.

2:30

Managing Consent as Data Privacy is Impacted by an Evolving
Automated Landscape

Ywe Looper
Head, Legal and Compliance
Boehringer Ingelheim Canada

3:15

Key Strategies for Maintaining Compliant Interactions with the Drug Supply Chain

Mathieu Gagné, LLM, LLD
Partner
Fasken, LLP

4:00

Close of Conference